aTyr Pharma, Inc. (ATYR)
0.8553
+0.02
(+2.99%)
USD |
NASDAQ |
Apr 17, 13:14
aTyr Pharma Research and Development Expense (Quarterly) : 10.89M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Liquidia Corp. | 16.72M |
| Agenus, Inc. | 7.511M |
| Curis, Inc. | 5.825M |
| Plus Therapeutics, Inc. | 2.941M |
| Windtree Therapeutics, Inc. | 1.537M |